Clinical trial
Evaluation of the Short-term Use of Selected PEP and OPEP Devices in Cystic Fibrosis Patients During an Exacerbation of the Disease
NCT05801952 is registered in ClinicalTrials.gov with National Institute for Tuberculosis and Lung Diseases, Poland as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Short-term Use of Selected PEP and OPEP Devices in Cystic Fibrosis Patients During an Exacerbation of the Disease
- Lead sponsor
- National Institute for Tuberculosis and Lung Diseases, Poland
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 1, 2020
- Completion date
- February 28, 2025
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.